These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Composition of essential oil of Chinese Chenopodium ambrosioides and insecticidal activity against maize weevil, Sitophilus zeamais. Chu SS; Feng Hu J; Liu ZL Pest Manag Sci; 2011 Jun; 67(6):714-8. PubMed ID: 21360645 [TBL] [Abstract][Full Text] [Related]
43. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin. Grogl M; Schuster BG; Ellis WY; Berman JD J Parasitol; 1999 Apr; 85(2):354-9. PubMed ID: 10219319 [TBL] [Abstract][Full Text] [Related]
44. Effect of Bixa orellana against Leishmania amazonensis. García M; Monzote L; Montalvo AM; Scull R Forsch Komplementmed; 2011; 18(6):351-3. PubMed ID: 22189367 [TBL] [Abstract][Full Text] [Related]
45. A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate. Barroso PA; Marco JD; Calvopina M; Kato H; Korenaga M; Hashiguchi Y J Antimicrob Chemother; 2007 Jun; 59(6):1123-9. PubMed ID: 17439977 [TBL] [Abstract][Full Text] [Related]
46. Efficacy of orally administered 2-substituted quinolines in experimental murine cutaneous and visceral leishmaniases. Nakayama H; Loiseau PM; Bories C; Torres de Ortiz S; Schinini A; Serna E; Rojas de Arias A; Fakhfakh MA; Franck X; Figadère B; Hocquemiller R; Fournet A Antimicrob Agents Chemother; 2005 Dec; 49(12):4950-6. PubMed ID: 16304157 [TBL] [Abstract][Full Text] [Related]
47. In-vitro and in-vivo studies on a topical formulation of sitamaquine dihydrochloride for cutaneous leishmaniasis. Garnier T; Brown MB; Lawrence MJ; Croft SL J Pharm Pharmacol; 2006 Aug; 58(8):1043-54. PubMed ID: 16872550 [TBL] [Abstract][Full Text] [Related]
48. Antileishmanial and immunomodulatory effects of the essential oil from Tetradenia riparia (Hochstetter) Codd. Demarchi IG; Terron Mde S; Thomazella MV; Mota CA; Gazim ZC; Cortez DA; Aristides SM; Silveira TG; Lonardoni MV Parasite Immunol; 2016 Jan; 38(1):64-77. PubMed ID: 26615004 [TBL] [Abstract][Full Text] [Related]
49. Amphotericin B resistance in Leishmania amazonensis: In vitro and in vivo characterization of a Brazilian clinical isolate. Ferreira BA; Coser EM; de la Roca S; Aoki JI; Branco N; Soares GHC; Lima MIS; Coelho AC PLoS Negl Trop Dis; 2024 May; 18(5):e0012175. PubMed ID: 38768213 [TBL] [Abstract][Full Text] [Related]
50. Radical cure of experimental cutaneous leishmaniasis by the bisphosphonate pamidronate. Rodriguez N; Bailey BN; Martin MB; Oldfield E; Urbina JA; Docampo R J Infect Dis; 2002 Jul; 186(1):138-40. PubMed ID: 12089677 [TBL] [Abstract][Full Text] [Related]
51. Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru. Llanos-Cuentas A; Tulliano G; Araujo-Castillo R; Miranda-Verastegui C; Santamaria-Castrellon G; Ramirez L; Lazo M; De Doncker S; Boelaert M; Robays J; Dujardin JC; Arevalo J; Chappuis F Clin Infect Dis; 2008 Jan; 46(2):223-31. PubMed ID: 18171254 [TBL] [Abstract][Full Text] [Related]
52. In vivo studies on the antileishmanial activity of buparvaquone and its prodrugs. Garnier T; Mäntylä A; Järvinen T; Lawrence J; Brown M; Croft S J Antimicrob Chemother; 2007 Oct; 60(4):802-10. PubMed ID: 17715126 [TBL] [Abstract][Full Text] [Related]
53. Evaluation of antileishmanial activity of eupomatenoid-5, a compound isolated from leaves of Piper regnellii var. pallescens. Vendrametto MC; Santos AO; Nakamura CV; Dias Filho BP; Cortez DA; Ueda-Nakamura T Parasitol Int; 2010 Jun; 59(2):154-8. PubMed ID: 20064628 [TBL] [Abstract][Full Text] [Related]
54. Chemistry, cytotoxicity and antileishmanial activity of the essential oil from Piper auritum. Monzote L; García M; Montalvo AM; Scull R; Miranda M Mem Inst Oswaldo Cruz; 2010 Mar; 105(2):168-73. PubMed ID: 20428676 [TBL] [Abstract][Full Text] [Related]
55. Increase of cellular recruitment, phagocytosis ability and nitric oxide production induced by hydroalcoholic extract from Chenopodium ambrosioides leaves. Cruz GV; Pereira PV; Patrício FJ; Costa GC; Sousa SM; Frazão JB; Aragão-Filho WC; Maciel MC; Silva LA; Amaral FM; Barroqueiro ES; Guerra RN; Nascimento FR J Ethnopharmacol; 2007 Apr; 111(1):148-54. PubMed ID: 17156956 [TBL] [Abstract][Full Text] [Related]
56. Effect of HIV protease inhibitors on New World Leishmania. Demarchi IG; Silveira TG; Ferreira IC; Lonardoni MV Parasitol Int; 2012 Dec; 61(4):538-44. PubMed ID: 22579524 [TBL] [Abstract][Full Text] [Related]
57. Activity of a paromomycin hydrophilic formulation for topical treatment of infections by Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis. Gonçalves GS; Fernandes AP; Souza RC; Cardoso JE; de Oliveira-Silva F; Maciel FC; Rabello A; Ferreira LA Acta Trop; 2005 Feb; 93(2):161-7. PubMed ID: 15652330 [TBL] [Abstract][Full Text] [Related]
58. Miltefosine--discovery of the antileishmanial activity of phospholipid derivatives. Croft SL; Engel J Trans R Soc Trop Med Hyg; 2006 Dec; 100 Suppl 1():S4-8. PubMed ID: 16904717 [TBL] [Abstract][Full Text] [Related]
59. In vitro and in vivo activity of a palladacycle complex on Leishmania (Leishmania) amazonensis. Paladi Cde S; Pimentel IA; Katz S; Cunha RL; Judice WA; Caires AC; Barbiéri CL PLoS Negl Trop Dis; 2012; 6(5):e1626. PubMed ID: 22616018 [TBL] [Abstract][Full Text] [Related]
60. Effectiveness of the local or oral delivery of the novel naphthopterocarpanquinone LQB-118 against cutaneous leishmaniasis. da Cunha-Júnior EF; Pacienza-Lima W; Ribeiro GA; Netto CD; do Canto-Cavalheiro MM; da Silva AJ; Costa PR; Rossi-Bergmann B; Torres-Santos EC J Antimicrob Chemother; 2011 Jul; 66(7):1555-9. PubMed ID: 21531758 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]